Hematopoiesis is a regulated developmental cascade that provides an accessible model system in mammals to study the development of distinct lineages. However, the regulatory pathways that control hematopoiesis are as yet poorly understood. The proto-oncogene PU.1/Spi-1 was originally cloned as the of site of retroviral integration in Friend virus induced erythroleukemias. Deregulation of PU.1 has subsequently been shown to be sufficient for erythroblast transformation. PU.1 has also been suggested to be a regulator of hematopoiesis based on its restricted expression pattern (primarily in B-cells and monocytes). To better understand the function of PU.1 during hematopoiesis, the gene was targeted via homologous recombination in embryonic stem (ES) cells and """"""""knock-out"""""""" mice were generated. Analysis of the hematopoietic system revealed that lymphoid and myeloid development was completely abrogated in mutant embryos (Scott et al., 1994). In vitro clonogenic and radioprotection assays with PU.1-/- hematopoietic cells have demonstrated that the defect in myeloid and lymphoid development is cell intrinsic. In addition, the myeloid differentiative capacity of PU.1 -/- ES cells can be rescued with a transgene which expresses PU.l under the control of its own promoter. The ability to """"""""rescue"""""""" PU.1-/- ES cells allows the determination of which functional domains of the PU.1 protein and which cis-regulatory promoter elements are required for myeloid and lymphoid differentiation. The role of PU.1 in the later stages of myeloid and lymphoid development also remains to be determined. In order to further our understanding of the role that PU.1 plays during hematopoiesis, we propose the following Specific Aims:
Aim I. To establish in vivo the functional domains of the PU.1 protein required for myeloid and lymphoid development.
Aim II. To establish in vivo the PU.1 regulatory elements necessary for myeloid and lymphoid development.
Aim III. Determine the role of PU.1 in the later stages of lymphoid and myeloid development.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Mufson, R Allan
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Slayton, William B; Li, Xiao-Miao; Butler, Jason et al. (2007) The role of the donor in the repair of the marrow vascular niche following hematopoietic stem cell transplant. Stem Cells 25:2945-55
Marshall 2nd, Gregory P; Laywell, Eric D; Zheng, Tong et al. (2006) In vitro-derived ""neural stem cells"" function as neural progenitors without the capacity for self-renewal. Stem Cells 24:731-8
Harris, Jeffrey R; Brown, Gary A J; Jorgensen, Marda et al. (2006) Bone marrow-derived cells home to and regenerate retinal pigment epithelium after injury. Invest Ophthalmol Vis Sci 47:2108-13
Slayton, William B; Wainman, David A; Li, Xiao Miao et al. (2005) Developmental differences in megakaryocyte maturation are determined by the microenvironment. Stem Cells 23:1400-8
Fisher, Robert C; Slayton, William B; Chien, Christopher et al. (2004) PU.1 supports proliferation of immature erythroid progenitors. Leuk Res 28:83-9
Cogle, Christopher R; Wainman, David A; Jorgensen, Marda L et al. (2004) Adult human hematopoietic cells provide functional hemangioblast activity. Blood 103:133-5
Grant, Maria B; Caballero, Sergio; Brown, Gary A J et al. (2003) The contribution of adult hematopoietic stem cells to retinal neovascularization. Adv Exp Med Biol 522:37-45
Grant, Maria B; May, W Stratford; Caballero, Sergio et al. (2002) Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 8:607-12
Guerriero, A; Langmuir, P B; Spain, L M et al. (2000) PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells. Blood 95:879-85
Wang, X; Scott, E; Sawyers, C L et al. (1999) C/EBPalpha bypasses granulocyte colony-stimulating factor signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32D cl3 myeloblasts. Blood 94:560-71

Showing the most recent 10 out of 14 publications